Total raised in public, private and other financings of biopharma companies, comparing 2019 vs. 2018.

Year-to-date money raised in public, private and other financings of biopharma companies.

Deals between biopharma companies and government or nonprofit entities in August 2019.

Deals between biopharma companies and government or nonprofit entities in September 2019.

Deals between biopharma companies and government or nonprofit entities in October 2019.

Deals between biopharma companies and government or nonprofit entities in November 2019.

The top 10 biopharma stock gainers and losers for the week.

SINGAPORE – Population-based cancer registries were a frequent focus of discussion at the ESMO Asia Congress.

After a two-month 32% swoon in the value of the BioWorld Gene Therapy index, it has managed to recover 6% of that loss since the end of September. Contributing to the recovery was Menlo Park, Calif.-based Adverum Biotechnologies Inc., whose shares (NASDAQ:ADVM) jumped almost 80% in the period.